Sekar Kathiresan - 06 Jun 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role: Director
Signature: /s/ Brian Adams, as Attorney-in-Fact
Issuer symbol: RLAY
Transactions as of: 06 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2025, 17:51:29 UTC
Previous filing: 03 Apr 2025
Next filing: 28 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kathiresan Sekar	Director	C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE	/s/ Brian Adams, as Attorney-in-Fact	06 Jun 2025	0001864112

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RLAY	Stock Option (Right to Buy)	Award	$0	+136,681		$0.000000	136,681	06 Jun 2025	Common Stock	136,681	$3.36	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.